Myeloid Cell IL-10 Production in Response to Leishmania Involves Inactivation of Glycogen Synthase Kinase-3β Downstream of Phosphatidylinositol-3 Kinase-Reference-Cited by-同舟云学术

Myeloid Cell IL-10 Production in Response to Leishmania Involves Inactivation of Glycogen Synthase Kinase-3β Downstream of Phosphatidylinositol-3 Kinase

Published:2011-12-02 Issue:1 Volume:188 Page:367-378
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Nandan Devki,Camargo de Oliveira Carolina,Moeenrezakhanlou Alireza,Lopez Martin,Silverman Judith M.,Subek Jennifer,Reiner Neil E.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference62 articles.

1. Trafficking of Leishmania donovani promastigotes in non-lytic compartments in neutrophils enables the subsequent transfer of parasites to macrophages.;Gueirard;Cell. Microbiol.,2008

2. The impact of vector-mediated neutrophil recruitment on cutaneous leishmaniasis

3. Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection

4. Leishmania donovani engages in regulatory interference by targeting macrophage protein tyrosine phosphatase SHP-1

5. Subversion Mechanisms by Which Leishmania Parasites Can Escape the Host Immune Response: a Signaling Point of View

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using machine learning to dissect host kinases required for Leishmania internalization and development;Molecular and Biochemical Parasitology;2024-12

2. Using machine learning to dissect host kinases required forLeishmaniainternalization and development;2024-05-16

3. Discovery, SAR and mechanistic studies of quinazolinone-based acetamide derivatives in experimental visceral leishmaniasis;European Journal of Medicinal Chemistry;2023-09

4. Screening of traditional medicinal plant extracts and compounds identifies a potent anti-leishmanial diarylheptanoid fromSiphonochilus aethiopicus;Journal of Biomolecular Structure and Dynamics;2023-05-18

5. Emerging strategies and challenges of molecular therapeutics in antileishmanial drug development;International Immunopharmacology;2023-02